Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F8ZYQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,832
Award facts
- Contract value 100% obligated
- $10,832.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,832.44 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on a firm fixed-price basis. The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication indicated for diabetes management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's primary IDC with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This global pharmaceutical prime vendor contract enables the company to supply a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's continued selection for pharmaceutical supply reflects its established capability to meet federal procurement requirements and support critical medical needs across the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26F8ZYQ?
SPE2DR26F8ZYQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F8ZYQ worth?
The government has obligated $10,832 on SPE2DR26F8ZYQ.
Is contract SPE2DR26F8ZYQ an order under another contract?
Yes. SPE2DR26F8ZYQ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZYQ competed?
The extent of competition for SPE2DR26F8ZYQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award